BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8781580)

  • 1. Genetic toxicology of mitotic spindle inhibitors used as anticancer drugs.
    Kirsch-Volders M; Parry EM
    Mutat Res; 1996 Aug; 355(1-2):103-28. PubMed ID: 8781580
    [No Abstract]   [Full Text] [Related]  

  • 2. The Progress of the Anticancer Agents Related to the Microtubules Target.
    Olatunde OZ; Yong J; Lu C
    Mini Rev Med Chem; 2020; 20(20):2165-2192. PubMed ID: 32727327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assault on the mitotic spindle. The action mechanism of taxane].
    Bartsch V
    Pharm Unserer Zeit; 2005; 34(2):104-8. PubMed ID: 15803793
    [No Abstract]   [Full Text] [Related]  

  • 4. Past and future of the mitotic spindle as an oncology target.
    Wood KW; Cornwell WD; Jackson JR
    Curr Opin Pharmacol; 2001 Aug; 1(4):370-7. PubMed ID: 11710735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticancer substances of vegetable origin. Spindle poisons: vincaleukoblastine, leurocristine and navelbine; taxol and taxotere].
    Guéritte-Voegelein F; Guénard D; Potier P
    C R Seances Soc Biol Fil; 1992; 186(5):433-40. PubMed ID: 1363958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
    Wilson L; Jordan MA
    J Chemother; 2004 Nov; 16 Suppl 4():83-5. PubMed ID: 15688618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
    Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
    Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and mechanism of millepachine-disrupted spindle assembly in tumor cells.
    Wu W; Liu F; Su A; Gong Y; Zhao W; Liu Y; Ye H; Zhu J
    Anticancer Drugs; 2018 Jun; 29(5):449-456. PubMed ID: 29649038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.
    Kawamura KI; Grabowski D; Weizer K; Bukowski R; Ganapathi R
    Br J Cancer; 1996 Jan; 73(2):183-8. PubMed ID: 8546904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic index, tubulin binders, and clinical medicine.
    Budman DR
    Cancer Invest; 2005; 23(5):479-80. PubMed ID: 16193646
    [No Abstract]   [Full Text] [Related]  

  • 11. Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells.
    Holy JM
    Mutat Res; 2002 Jun; 518(1):71-84. PubMed ID: 12063069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The organization of the mitotic apparatus poles in etoposide-treated CHO-K1 cells].
    Balashova EE; Riaskina SS; Vinogradova TM; Bystrevskaia VB
    Tsitologiia; 2008; 50(5):420-9. PubMed ID: 18683588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new bis-indole, KARs, induces selective M arrest with specific spindle aberration in neuroblastoma cell line SH-SY5Y.
    Comín-Anduix B; Agell N; Bachs O; Ovádi J; Cascante M
    Mol Pharmacol; 2001 Dec; 60(6):1235-42. PubMed ID: 11723230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules.
    Di Cesare E; Verrico A; Miele A; Giubettini M; Rovella P; Coluccia A; Famiglini V; La Regina G; Cundari E; Silvestri R; Lavia P
    Oncotarget; 2017 Mar; 8(12):19738-19759. PubMed ID: 28160569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tools for the antimitotic toolbox.
    Compton DA
    Science; 1999 Oct; 286(5441):913-4. PubMed ID: 10577242
    [No Abstract]   [Full Text] [Related]  

  • 16. Spindle formation in Aspergillus is coupled to tubulin movement into the nucleus.
    Ovechkina Y; Maddox P; Oakley CE; Xiang X; Osmani SA; Salmon ED; Oakley BR
    Mol Biol Cell; 2003 May; 14(5):2192-200. PubMed ID: 12802085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress on kinesin spindle protein inhibitors as anti-cancer agents.
    Zhang Y; Xu W
    Anticancer Agents Med Chem; 2008 Aug; 8(6):698-704. PubMed ID: 18690830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic aspects on chemical induction of spindle disturbances and abnormal chromosome numbers.
    Onfelt A
    Mutat Res; 1986 Nov; 168(3):249-300. PubMed ID: 3540644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
    Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA
    Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.